Novo Nordisk A/S (NVO) News Today $85.00 -18.44 (-17.83%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period MarketBeat Week in Review – 12/16 - 12/20 (NVO)Stocks were lower this week after the Federal Reserve confirmed fewer rate cuts in 2025, but Friday's rally suggests hope for a Santa Claus rally remains strongDecember 21 at 7:00 AM | marketbeat.com3 Fantastic Stocks That Could Enjoy a Santa Claus RallyDecember 21 at 6:48 AM | fool.comHepion Pharmaceuticals (NASDAQ:HEPA) and Novo Nordisk A/S (NYSE:NVO) Financial ReviewDecember 21 at 3:05 AM | americanbankingnews.comNovo Nordisk A/S (NYSE:NVO) Upgraded by StockNews.com to "Strong-Buy" RatingStockNews.com raised shares of Novo Nordisk A/S from a "buy" rating to a "strong-buy" rating in a report on Saturday.December 21 at 2:22 AM | marketbeat.comUS FDA approves Novo Nordisk's bleeding disorder drugDecember 20 at 6:42 PM | reuters.comWhy Novo Nordisk's Stock Plunge Is Rattling MarketsDecember 20 at 5:40 PM | wsj.comNovo Nordisk's dosing in CagriSema obesity drug trial puzzles investorsDecember 20 at 12:27 PM | reuters.comWhy Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are UpDecember 20 at 12:20 PM | fool.comNovo Nordisk shares plummet after weight-loss drug's disappointing trial resultsDecember 20 at 12:00 PM | nypost.comNovo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030December 20 at 11:45 AM | 247wallst.comNovo Nordisk A/S (NYSE:NVO) Reaches New 12-Month Low - Time to Sell?Novo Nordisk A/S (NYSE:NVO) Sets New 12-Month Low - Here's What HappenedDecember 20 at 10:37 AM | marketbeat.comNovo Nordisk Stock: A Rare Buying OpportunityDecember 20 at 10:04 AM | seekingalpha.comNovo Nordisk shares drop after weight loss drug trial disappointsDecember 20 at 9:13 AM | proactiveinvestors.comNovo Nordisk Sinks on Disappointing Trial Results for Next Gen Weight Loss DrugDecember 20 at 8:30 AM | investopedia.comNovo Nordisk's new weight-loss drug works better, but not as well as expectedDecember 20 at 8:05 AM | marketwatch.comNovo Nordisk to explore CagriSema weight-loss potential in new trialDecember 20 at 7:55 AM | reuters.comNovo Nordisk A/S - share repurchase programmeDecember 20 at 7:47 AM | globenewswire.comNovo Nordisk shares plunge 22% after CagriSema obesity drug trial resultsDecember 20 at 6:28 AM | cnbc.comNovo Nordisk Stock Crashes 22% After Disappoitning Obesity Drug Data. Eli Lilly Shares Soar.December 20 at 6:20 AM | barrons.comNovo Nordisk's next-gen obesity drug CagriSema achieves lower weight loss than expectedDecember 20 at 5:51 AM | reuters.comNovo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trialDecember 20 at 5:41 AM | globenewswire.comFocus: In weight loss battle, Novo and Lilly face growing offensive from licenced copiesDecember 19 at 8:03 PM | reuters.comNovo Nordisk Is Ready to Ramp Up GLP-1 Manufacturing Following $11B Factory DealDecember 19 at 4:21 PM | barrons.comPetri Dish: Waltham biotech’s Novo Nordisk collab; Akari names CEO post mergerDecember 19 at 12:59 PM | bizjournals.comNovo Nordisk A/S (NVO) Fell as its Weight Loss Drug Faced Supply ConstraintsDecember 19 at 12:59 PM | msn.comNovo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030December 19 at 11:01 AM | 247wallst.comGot $250? 2 Healthcare Stocks to Buy and Hold ForeverDecember 19 at 6:15 AM | fool.comNovo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030December 18 at 11:19 AM | 247wallst.comNovo Nordisk: A New Boost for GLP-1 Sales on the HorizonNovo Nordisk A/S is moving closer to adding more sales for its blockbuster GLP-1 drug semaglutide to treat a chronic liver disease.December 18 at 10:38 AM | marketbeat.comNovo Holdings completes $16.5 bln takeover of CatalentDecember 18 at 9:08 AM | reuters.comPhotys Therapeutics Announces Research Collaboration with Novo Nordisk to Develop Induced Proximity PHICS Technology for Cardiometabolic DiseasesDecember 18 at 7:30 AM | globenewswire.comOzempic Dethroned? A Head-to-Head Study Confirms This Company Has the Best Weight Loss DrugDecember 18 at 6:15 AM | fool.comNovo Nordisk's Ozempic faces EU review for potential eye disease connectionDecember 18 at 4:27 AM | reuters.comNovo Nordisk’s hiring binge leaves Danish firms starved of laborDecember 17, 2024 | finance.yahoo.comNovo Nordisk's Ozempic potentially investigated for rare eye conditionDecember 17, 2024 | msn.comHealthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye conditionDecember 17, 2024 | cnbc.comIs Novo Nordisk A/S (NVO) the Best Weight Loss Stock to Buy Now According to Hedge Funds?December 17, 2024 | insidermonkey.comBrokerages Set Novo Nordisk A/S (NYSE:NVO) PT at $150.40December 17, 2024 | americanbankingnews.comNovo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030December 16, 2024 | 247wallst.comNovo's Ozempic faces scrutiny over potential link to rare eye diseaseDecember 16, 2024 | reuters.comNovo Nordisk to park $1.2 billion in new plant in Denmark for rare disease drugsDecember 16, 2024 | msn.comNovo Nordisk A/S - share repurchase programmeDecember 16, 2024 | globenewswire.comToronto Dominion Bank Sells 19,858 Shares of Novo Nordisk A/S (NYSE:NVO)Toronto Dominion Bank trimmed its stake in Novo Nordisk A/S (NYSE:NVO - Free Report) by 57.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,863 shares of the company's stock after selling 19,858 shares dDecember 16, 2024 | marketbeat.comWeight-loss Drugmaker Novo Nordisk Invests $1.2 Bn In New Factory In DenmarkDecember 16, 2024 | barrons.comNovo Nordisk Invests $1.2 Billion in New Factory in DenmarkDecember 16, 2024 | bloomberg.comNovo Nordisk To Invest DKK 8.5 Bln For New Production Facility In DenmarkDecember 16, 2024 | markets.businessinsider.comNovo Nordisk to invest $1.2 bln in new plant in DenmarkDecember 16, 2024 | reuters.comNovo Nordisk invests DKK 8.5 billion in new production facility in Odense, DenmarkDecember 16, 2024 | globenewswire.comB. Riley Wealth Advisors Inc. Has $4.62 Million Stock Holdings in Novo Nordisk A/S (NYSE:NVO)B. Riley Wealth Advisors Inc. trimmed its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 33.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 39,482 shares of the company's stock after sellingDecember 15, 2024 | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Cut to "Buy" at StockNews.comDecember 15, 2024 | americanbankingnews.com Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss. Click Here to get the full details about Crypto’s Hidden Gem NVO Media Mentions By Week NVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVO News Sentiment▼0.270.61▲Average Medical News Sentiment NVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVO Articles This Week▼5028▲NVO Articles Average Week Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AstraZeneca News Today Novartis News Today Sanofi News Today GSK News Today Takeda Pharmaceutical News Today BioNTech News Today Teva Pharmaceutical Industries News Today BeiGene News Today Moderna News Today Viatris News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
